跳至主要内容
临床试验/NCT03932604
NCT03932604Unknown不适用

A Prospective, Multicenter, Randomized Controlled Trial Comparing Atrial Sensing ON-mode of VDD Implantable Cardioverter Defibrillator(ICD) to Atrial Sensing OFF-mode of VDD ICD in Detecting Atrial Fibrillation(Smart-Control Study)

Samsung Medical Center28 个研究点 分布在 1 个国家目标入组 640 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
640
试验地点
28
主要终点
Atrial fibrillation

研究概览

简要总结

This prospective multi-center randomized controlled study aims to compare atrial fibrillation detection and inappropriate therapy according to activation of atrial sensing capability in patients with implantable cardioverter defibrillator.

详细描述

Implantable cardioverter defibrillators(ICD) therapy has been shown to reduce sudden cardiac death and improve survival in cardiac arrest survivors as well as in heart failure patients with left ventricular dysfunction.

Atrial fibrillation (AF) is commonly found in ICD implantation patients up to 50%. AF is an independent predictor of mortality, inappropriate shock, and embolic events. Therefore, early detection of AF in patients with ICD is essential for improving the quality of life and overall prognosis of the patients.

Conventional ICDs consist of a single chamber (SC) ICD with a lead only in the right ventricle (RV) and dual chamber (DC) ICD with each lead in the right atrium (RA) and RV. SC ICD has the advantage of shorter procedure time, lower cost compared to DC ICD. In contrast, DC ICD has the advantage of being able to monitor atrial arrhythmic events, but complication rates were higher and additional cost and longer procedure time are usually required than SC ICD. Sixty percent of ICD implantation patients who have are SC ICD Recently, a unique ICD lead with atrial sensing ring capable of monitoring the atrial electrical signals has been developed [Intica 7 VR-T DX ICD (Biotronik., Germany)]. Therefore, turning off the atrial sensing function makes it functionally the same as SC ICD whereas turning on makes it function similar to DC ICD without additional cost and procedure time.

Therefore, Detection of AF could be made earlier with VDD ICD versus conventional SC ICD without atrial sensing capability, providing a better chance to improve the prognosis of ICD patients. However, no study exists which shows whether VDD ICD is better for detecting atrial tachyarrhythmia than conventional SC ICD. Therefore, we designed a multicenter prospective randomized study comparing the AF diagnostic efficacy of VDD ICD (with atrial sensing 'ON') against conventional SC ICD. As the second phase, we also plan to compare inappropriate therapy rate according to atrial sensing status of VDD ICD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 19 years
  • indication for ICD implantation according to guidelines
  • atrial fibrillation didn't detect by electrocardiogram or Holter test within the past 1 year from the ICD implantation, and
  • CHA2DS2VASc score ≥1 point in male or ≥ 2 in female

排除标准

  • persistent or permanent atrial fibrillation (AF)
  • atrial fibrillation detected by electrocardiogram or Holter test within the past 1 year from the ICD implantation
  • history of the catheter or surgical ablation of AF or taking antiarrhythmic drug
  • scheduled to undergo heart transplant within 1 year
  • life expectancy < 1 year
  • requiring atrial pacing

结局指标

主要结局

Atrial fibrillation

时间窗: from enrollment to last follow-up (2 years)

cardiac implantable electronic device-detected or clinical atrial fibrillation

Inappropriate device therapy

时间窗: from enrollment to last follow-up (2 years)

inappropriate ATP or shock

次要结局

  • Number of Participants with ventricular arrhythmia(from enrollment to last follow-up (2 years))
  • atrial lead sensing stability(from enrollment to last follow-up (2 years))
  • Number of Participants with complications associated with atrial fibrillation(from enrollment to last follow-up (2 years))
  • Number of Participants with major adverse composite events(from enrollment to last follow-up (2 years))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验

Atrial Sensing Capability for Better Detection of... | 临床试验